Hepatitis Forums

Hepatitis B Main Forums => Hepatitis B => Topic started by: Hep Editors on March 12, 2018, 10:58:15 am

Title: People With Well-Treated Hep B Have Similar Survival Rates to Those Without
Post by: Hep Editors on March 12, 2018, 10:58:15 am

Individuals with hepatitis B virus (HBV) who are taking Baraclude (entecavir) and Viread (tenofovir disoproxil fumarate) have similar eight-year survival rates to those in the general population, Healio reports. The exception is those people with HBV and hepatocellular carcinoma (HCC, the most common form of liver cancer).

Publishing their findings in the Journal of Hepatology, researchers conducted a study in 1,951 people with hep B who were on Baraclude and Viread. A total of 526 of this group had compensated cirrhosis (the milder form of the advanced liver disease).

Read more...
https://www.hepmag.com/article/people-welltreated-hep-b-similar-survival-rates-without